Lowest Price for Guanfacine HCl - Vildagliptin CAS 274901-16-5 Type 2 Diabetes Mellitus (T2DM) API High Purity – Ruifu
Lowest Price for Guanfacine HCl -Vildagliptin CAS 274901-16-5 Type 2 Diabetes Mellitus (T2DM) API High Purity– RuifuDetail:
Manufacturer with High Purity and Competitive Price
Supply Vildagliptin and Related Intermediates:
Vildagliptin CAS: 274901-16-5
3-Amino-1-hydroxyadamantane CAS: 702-82-9
L-Prolinamide CAS: 7531-52-4
Boc-L-Proline CAS: 15761-39-4
(2S)-1-(Chloroacetyl)-2-pyrrolidinecarbonitrile CAS: 207557-35-5
| Chemical Name | Vildagliptin |
| Synonyms | LAF-237 |
| CAS Number | 274901-16-5 |
| CAT Number | RF-API30 |
| Stock Status | In Stock, Production Scale Up to Hundreds of Kilograms |
| Molecular Formula | C17H25N3O2 |
| Molecular Weight | 303.4 |
| Brand | Ruifu Chemical |
| Item | Specifications |
| Appearance | Off-White to White Crystalline Powder |
| Identification | HPLC: Similar to working standard |
| Specific Optical Rotation | -82.0° to -92.0° |
| Loss on Drying | ≤0.50% |
| Residue on Ignition | ≤0.10% |
| Purity / Analysis Method | ≥99.0% (HPLC) |
| Heavy Metals | ≤20ppm |
| Test Standard | Enterprise Standard |
| Usage | Active Pharmaceutical Ingredient (API) |
Package: Bottle, Aluminum foil bag, Cardboard drum, 25kg/Drum, or according to customer’s requirement.
Storage Condition: Store in sealed containers at cool and dry place; Protect from light, moisture and pest infestation.
Shanghai Ruifu Chemical Co., Ltd. is the leading manufacturer and supplier of Vildagliptin (CAS: 274901-16-5) with high quality.
Vildagliptin (also known as LAF237 and Zomelis) is an oral anti-hyperglycemic agent (anti-diabetic drug) of the new dipeptidyl peptidase-4 (DPP-4) inhibitor class of drugs. Vildagliptin inhibits the inactivation of GLP-1 and GIP by DPP-4, allowing GLP-1 and GIP to potentiate the secretion of insulin in the beta cells and suppress glucagon release by the alpha cells of the islets of Langerhans in the pancreas. Vildagliptin has been shown to reduce hyperglycemia in type 2 diabetes mellitus. Novartis has since withdrawn its intent to submit vildagliptin to the FDA, as of July 2008. T it was approved in Feb 2008 by European Medicines Agency for use within the EU and is listed on the Australian PBS with certain restrictions.
Product detail pictures:
Related Product Guide:
With a positive and progressive attitude to customer's interest, our enterprise continually improves our products excellent to meet the wants of customers and further focuses on safety, reliability, environmental requirements, and innovation of Lowest Price for Guanfacine HCl -Vildagliptin CAS 274901-16-5 Type 2 Diabetes Mellitus (T2DM) API High Purity– Ruifu, The product will supply to all over the world, such as: Greece, Bogota, Estonia, With the goal of "zero defect". To care for the environment, and social returns, care employee social responsibility as own duty. We welcome friends from all over the world to visit and guide us so that we can achieve the win-win goal together.
